Can You Mail Peptides? Shipping Rules to Verify

Can you mail peptides?

Whether you can mail peptides depends on the exact item, sender, destination, service, and applicable law. USPS guidance places responsibility for postal and relevant distribution rules on the mailer, but it does not classify an unnamed peptide. Establish the shipment facts, check the current rules that apply, and hold the parcel while any material question remains unresolved. [2]

Your useful answer is a decision for one defined shipment, backed by records another person can inspect. A website label, a past delivery, or an available postage option does not resolve missing classification. Build the decision from the item and route before anyone releases a parcel.

Key Facts

• USPS Publication 52 assigns the mailer responsibility for postal rules and applicable federal, state, and local distribution laws. That text does not decide the status of any unnamed peptide. [2]
• USPS asks mailers to understand material characteristics, including properties such as flammability, toxicity, or corrosiveness, that could affect mailability. [2]
• The USPS HAZMAT search tool describes separate results for air, surface, and international shipping for an item entered into that tool. A search result must be read for the actual material and method. [3]
• USPS requires detailed descriptions on customs forms for packages sent from the United States to another country and warns that an inadequate description can lead to return, refusal, or destruction by destination customs. [1]
• FDA describes an admissibility review for human drug shipments arriving through ports, courier hubs, and international mail facilities. That process applies only where the shipment is within the stated human drug scope. [4]

TL;DR

There is no useful blanket mailing answer for every item called a peptide. Build a shipment record that identifies the material and route, resolves the applicable legal and carrier questions, and names the person who approved the defined scenario. For international mail, add destination research and an accurate customs description; an unresolved field means hold the shipment.

Facts to establish before a peptide mailing decision

Establish the actual item and transaction before choosing a carrier or service. USPS says mailers are responsible for compliance with postal regulations and applicable distribution laws, and for understanding material characteristics that can affect mailability. Those are questions about the shipment in front of you, rather than permission for an entire category of products. [2]

Start with an item identity that survives a handoff

You may know the catalog nickname while a fulfillment worker sees a stock code, a container label, and a packing instruction. If those records cannot be reconciled, the worker cannot know whether a prior review applies. The intake record should therefore connect the commercial listing, internal identifier, technical description, formulation or physical form, and the exact item being packed. It should also say where that information came from. A blank technical field is an open question, not permission to substitute a broad label.

Use this intake table to gather facts before requesting a carrier or legal decision. It is a planning aid, not a USPS form or a legal classification.

Keep the classification question open until a qualified reviewer has enough facts to answer it. Do not fill that cell with a phrase copied from a product page. Supply what is present, what the parties plan to do, and where the item will travel. If the facts are insufficient, obtain the missing product record before the parcel enters the shipping queue.

Separate the decisions that share a shipping label

A label combines practical details on a single surface, but the underlying decisions come from different sources. One question is whether the transaction involving the item is lawful for these parties. Another is whether the chosen carrier accepts the material by the selected service. A third concerns physical preparation. A border crossing adds customs and destination requirements. USPS Publication 52 describes mailer responsibility for both postal regulations and applicable distribution laws. It does not collapse those inquiries into one approval. [2]

Imagine a carrier message confirming that a service reaches an address. That answer may resolve the route, but it may not classify the contents. A legal analysis of the transaction may also leave package preparation unanswered. Record each response under the question it resolves, with its date, scope, and source. Keep the shipment pending while any required decision remains open.

Use this decision tree as an internal control. It is not an agency workflow. An unresolved gate means hold the parcel while you gather the missing answer.

The HAZMAT tool illustrates why service detail matters. USPS says its result distinguishes air, surface, and international outcomes for the item entered. Its guidance also points to item specific packaging instructions when a material is within that tool's scope. The existence of the tool does not mean an unnamed peptide has been searched, is hazardous, or is mailable. [3] If a knowledgeable reviewer identifies a relevant material characteristic, record the exact search term, observed result, and linked instruction. If the reviewer cannot determine whether the tool applies, retain that uncertainty and ask USPS or a qualified specialist.

Record material facts without making an invented classification

USPS mentions flammability, toxicity, and corrosiveness as examples of characteristics a mailer should understand. [2] You do not need to guess that an item has one of those properties to make progress. Instead, request the material information from the documented product and packaging records. Include everything that would travel in the parcel, because a packaging component could raise a separate transport question. Then ask the appropriate reviewer what, if any, postal category or packaging instruction applies.

Consider a hypothetical order for an unnamed laboratory material. The catalog record says only “sample,” the packing slip uses an internal code, and no technical description is attached. You might know what the code usually represents, but a carrier inquiry based on “sample” would omit the most important fact. The correct outcome is a hold. The team connects the code to the actual material record, documents the full parcel contents, and restarts the review. Nothing in that scenario establishes whether the hypothetical material is mailable.

Now consider a second hypothetical parcel with complete item documentation but an unclear service. A surface result for a reviewed material cannot be carried over to an air service merely because both labels can be purchased. USPS presents method specific HAZMAT results. [3] Save the result for the proposed service and date, then ask what other restrictions apply. This example shows how a clear item record can still leave a shipment pending.

The legality guide frames the separate business question of whether a proposed product and sale are lawful. It is a useful prompt for questions to counsel, not an approval of a parcel. The shipping packaging guide helps the operations team describe what it intends to pack. Read the applicable carrier instructions directly before adopting any packaging condition.

Make “hold” an executable status

A hold needs an unresolved field, an owner, and a condition for renewed review. “Legal is looking at it” leaves the shipping team guessing. A useful internal note says the item record lacks verified composition, the legal reviewer needs it, and fulfillment must wait for a documented conclusion before releasing the parcel. This is a workflow example, not a legal requirement.

Will customs confiscate peptides?

Not automatically: no source here says customs will confiscate your peptide shipment, and none says it will not. Your outcome depends on the facts of your own parcel, which you should establish before you ship. USPS warns that a package sent from the United States without a detailed item description may be returned, refused, or potentially destroyed by destination customs. FDA describes a separate review and refusal process for imported human drugs within its scope. Neither statement forecasts the outcome of an unidentified parcel. [1] [4] [5]

Ask which border process the parcel actually enters

An outbound package from the United States and an inbound package entering it should not be placed in the same process column. For an outbound package, USPS explains that detailed descriptions are required on international customs forms and that destination countries have different declaration requirements. It says its online forms application can display country prohibitions, restrictions, and observations. [1] This supports a destination check, not an assumption that a country allows a specific material. Record the country, the source consulted, the result as shown, and any additional review needed for the item.

For an inbound shipment that is a human drug under FDA's described process, FDA says it reviews shipments at land and sea ports, courier hubs, and international mail facilities for admissibility into the United States. 4] This page does not classify the unnamed item or predict whether a particular shipment will be admitted. First resolve whether the process applies to the actual item and transaction, then record only the agency stage shown in the available notice. For a closer look, read [When a Peptide Shipment Arrives Broken: Protection, Claims, and Reship Policy.

This distinction matters when a package has stopped moving. A carrier tracking event is not the same as a formal agency decision. A message saying “held” may prompt investigation, but it does not by itself prove detention, refusal, destruction, or seizure under a specific authority. FDA defines refusal as its final decision that a detained shipment violates FDA laws and regulations. [5] Record the actual document and issuing agency before using that term for an individual case.

Write a truthful description from verified item facts

USPS says packages sent from the United States to another country need detailed item descriptions on customs forms. [1] Build that description from the verified item record before completing a form. Do not change a material's identity to make the parcel appear easier to ship.

The worksheet below is intentionally a set of questions, not a sample customs declaration. A fabricated declaration for an unclassified peptide would be misleading. The person preparing the form should fill it only from verified records and current USPS instructions, then send unresolved classification questions to the responsible expert.

Keep the plain language customs description and any separate classification question in different fields. Record the submitted wording, the reviewer, and any unresolved question. USPS says destination countries have different declaration requirements and that its online forms tool can show country restrictions. [1] A completed description is therefore one part of the destination review, not an approval for the goods.

For example, suppose a hypothetical outbound parcel contains an unnamed research material. The team has a technical record and a detailed draft description but has not checked the destination country's restrictions. The right status is pending destination review. A finished form is not a substitute for that missing result. In a different hypothetical scenario, the destination check exists but the parcel includes a second material absent from the form. The right status is pending correction and review of the complete contents. Neither hypothetical example claims an actual customs outcome.

Distinguish the event from the feared outcome

For this glossary, screening means reviewing imported human drug shipment data for possible violations as part of FDA's admissibility process. FDA describes data screening and physical examinations as parts of that approach. Screening does not, by itself, identify a final outcome for a particular parcel. [4]

Detention is FDA's formal action when a product violates or appears to violate its requirements, documented through a Notice of Detention and Hearing. That notice identifies the agency action; a carrier tracking pause is not a substitute for it. [6] Refusal is FDA's final decision that a detained shipment violates applicable FDA requirements. [5] Keep the definitions separate and use each label only when the actual case record supports it.

Use a status timeline to keep customer updates tied to records. Enter only events supported by a carrier or agency notice. If the source of a reported event is unclear, mark it unconfirmed and do not describe it as a final agency decision.

FDA's human drug import page describes the screening approach, while its refusal page supplies the narrow definition of refusal. [4] [5] The USPS customs page supplies a separate warning about return, refusal, or possible destruction where a detailed description is missing. [1] Do not combine those into a single “confiscation rate,” because the pages discuss different authorities and conditions. No such rate is supported here.

Build an incident packet before making a new shipping choice

When a parcel is delayed or receives an adverse notice, preserve the facts first: the item and packing record, submitted declaration, carrier and service, destination, tracking entries, and every agency communication. Record the date each item was received. Assign one owner to ask the carrier or relevant authority what the notice means. Counsel may need to review legal implications. The goal is to learn which earlier gate failed, if any, rather than change the next parcel's wording to escape attention.

A hypothetical incident illustrates the boundary. An outbound parcel's tracking page stops updating, and a buyer asks whether customs took it. The business has no agency notice. The support team can accurately state the observed tracking status and that it is seeking clarification; it should not announce a seizure. If a destination authority later sends a return notice citing an incomplete description, the team should attach that notice, compare the form to the verified item record, and review the relevant destination rule before proposing another shipment. This scenario gives a records response, not a promise of clearance.

Can you send peptides in the mail?

You can send peptides in the mail only after you have checked your particular item, sender, service, and route against the applicable rules, and until then you should hold the parcel. USPS describes item specific HAZMAT results by air, surface, and international method, while Publication 52 imposes separate rules for defined drug categories. Neither source supplies a general approval for all products marketed as peptides. [2] [3]

Test the proposed service, not the idea of “shipping”

“We use USPS” is not a complete shipping instruction. The team needs the named service and route, the material facts supplied for its review, and the exact result returned. USPS says its HAZMAT results distinguish air, surface, and international outcomes and link to item specific packaging instructions when relevant. [3] If the material belongs in that review, match the result to the actual item and proposed method. A vague catalog term is not enough for an item specific decision.

The source does not say every peptide is HAZMAT. It also does not provide the outcome of a search for the unnamed product in your warehouse. Ask the knowledgeable material or carrier reviewer whether the tool is applicable, then record the exact result and instruction if it is. If a result says a proposed service is prohibited, do not buy a different postage label until the new service and all remaining requirements are reviewed. USPS says an item shown as prohibited cannot be sent with USPS. [3]

The source record has no item specific acceptance statement from another carrier. Obtain that carrier's current terms or response for the proposed parcel. A competitor's shipping page or a label platform rate is not an acceptance decision for your item.

Check conditional drug rules without assigning a category by guesswork

USPS Publication 52 includes a section for drugs other than controlled substances. It says only pharmacists, medical practitioners, or other authorized dispensers may mail nonnarcotic prescription medications to patients under their care. 2] This is consequential when an actual item fits that category, but the rule cannot be applied merely because a product name contains the word peptide. Nor can you assume it is outside the rule because your marketing page uses a research label. For a closer look, read [How to Label a Peptide Vial: The Required Elements.

Give the reviewer the exact identity, parties, destination, and transaction. Ask whether that Publication 52 category or another part of the publication applies. Record the answer as a conclusion for those facts, not a reusable slogan. If the response depends on sender status, document how that status was established. If the status remains unresolved, the mailing decision remains unresolved. The question here is classification and authority; this article does not instruct anyone on product use.

Publication 52 also states that mailers must understand characteristics that may affect mailability. 2] A practical review should therefore describe the whole parcel, including any packaging component that raises a separate question. The [shipping stability guide helps organize questions about preserving the material during transit. A stability plan, however, does not decide legal classification or carrier acceptance. Ask for separate answers and retain both.

Translate an applicable packaging result into an operator instruction

If a relevant USPS HAZMAT search returns a mailable result for a specific item and method, USPS directs the user to linked packaging instructions that include quantity limits, packaging, and labeling requirements. [3] The useful operating step is to identify the exact instruction, compare each applicable condition with the proposed package, and keep the comparison with the reviewed scenario. Do not write “use sturdy packaging” as a substitute for an applicable instruction whose content has not been read.

This table is a comparison format, not a list of universal USPS packaging requirements for peptides. You should not copy values from another product's instruction. A named reviewer must first establish applicability. The fulfillment cold chain checklist can help assign who gathers package evidence and who checks a vendor's process, while the actual carrier conditions remain in the source instruction.

Compare two hypothetical service requests

Suppose a hypothetical domestic order has an exact item record and a proposed USPS service. The team finds an applicable source for sender authority and product status but has not recorded the parcel's complete packaging components. That order is pending package review. The team asks the packer for the assembly record, evaluates any component that affects transport, and then has the designated reviewer compare the package with the applicable instructions. The fact that the item record is complete does not close the package question.

Suppose a hypothetical international order uses the same item but a different USPS service and destination. A domestic answer does not resolve international acceptance, and the new destination requires its own declaration and restriction review. USPS distinguishes methods in its HAZMAT results and says destination customs requirements differ. [1] [3] The team should create a new scenario record rather than changing the destination on the old approval. Both examples end at pending because this article has no item specific ruling.

Is it legal to transport peptides?

The answer depends on the identified item, parties, activity, and jurisdictions. USPS places responsibility for postal requirements and applicable distribution laws on the mailer; it does not give a legal ruling for an unnamed peptide. A qualified reviewer must decide which laws apply before you consider a proposed transfer lawful. [2]

Give counsel a transaction, not a slogan

A useful request for legal review describes who owns the material, who sends it, who receives it, what will change hands, and where it travels. It includes the actual product and marketing records because the reviewer may need to assess how the business presents and transfers the item. It identifies whether the route stays within one jurisdiction or crosses a border. “We sell research products” provides too little detail to resolve any of those questions.

Ask for a written conclusion with a defined scope. Which item and formulation did the reviewer consider? Which sender and recipient roles were assumed? Does the answer cover a domestic transaction, an export, an import, or only one of those? Which open fact would change the conclusion? These are questions to help you commission an analysis; they are not a claim that a particular law requires this exact memo format.

The review should distinguish product and transaction legality from postal service acceptance. USPS Publication 52 addresses mailer responsibility for both postal rules and relevant federal, state, and local distribution laws. [2] A carrier's ability to print a label cannot determine all those legal questions. The reverse is also true: a legal view of a transaction does not tell the fulfillment team which service and package conditions apply. Keep separate signoffs so neither answer is silently borrowed by the other team.

Treat the product label as evidence, not a verdict

You may wonder whether a research label settles shipment status. It does not establish the physical identity of the item, the sender's authority, the chosen service's rules, or the destination's requirements. The label may be one fact a qualified reviewer considers, but the decision needs the full record. USPS's item and mailer responsibility language is framed around the actual article and applicable laws, not a magic phrase on a listing. [2]

An editorial review prompt can make this concrete. Put the commercial listing beside the technical product record and proposed shipping description. If the three describe the item differently, do not ask fulfillment to decide which one is “real.” Assign the discrepancy to the person who owns product records, then return the reconciled facts to legal and carrier reviewers. The carrier should see accurate facts, and the legal reviewer should know what the business actually offers.

Suppose a hypothetical seller labels an unnamed material for laboratory research, while its parcel description is only “accessories.” The mismatch is an immediate hold. The task is not to choose a more convenient phrase. It is to determine what the parcel contains, correct the business record, and ask the relevant reviewers how the true item may be described and whether the contemplated shipment can occur. No legal outcome for that hypothetical material follows from this example.

Keep jurisdiction questions in separate rows

The mailer responsibility section of USPS Publication 52 specifically refers to federal, state, and local laws governing distribution. [2] An international route can add the destination's import requirements. USPS also says destination countries have different customs declaration requirements and offers country restriction information through its customs forms application. [1] These statements explain why a single national rule summary cannot approve every destination. They do not identify a particular country's rule for a particular peptide.

The FDA row has a narrow source basis. FDA describes how it reviews imported human drug shipments at several entry channels, including international mail facilities. [4] That page does not classify every substance called a peptide as a human drug or determine the status of an outbound shipment to another country. The destination row has a different source basis: USPS says declarations vary by country, but the applicable country rule still has to be checked. [1]

Resolve conflicting answers before making a promise

If two reviewers appear to disagree, first compare their questions and facts. One may have addressed a domestic route while the other considered an international one. One may have evaluated the item alone while the other evaluated the whole parcel. Save both responses with their dates and the exact question asked. Then request a reconciliation from the relevant authority or qualified professional. Do not let a fulfillment deadline choose between incompatible answers.

A useful conclusion uses bounded language: a defined item, parties, route, service, and set of conditions were reviewed as of a date, with open issues listed separately. Avoid a standing statement that “transporting peptides is legal.” That statement would exceed the source record and invite reuse when the facts change. The approval owner should reopen the file if a product record, sender role, destination, service, or relevant source changes. The guide Peptide Product Recall and Mock-Recall Drill: A Bounded Operator Workflow covers this in more detail.

Shipping records to verify

Verify a shipment specific chain from product identity through legal review, carrier and service response, package preparation, destination check, declaration, and final release. Keep the primary source, access date, exact scenario, and reviewer for every conclusion. USPS and FDA describe different parts of this chain; no single page certifies the whole shipment. [1] [2] [3] [4]

Build a file another operator can use

A new fulfillment owner should be able to reconstruct why a parcel was released or held. Screenshots need a scenario description so their scope is clear. Approval notes need the source and facts considered. Store each answer beside its evidence, and list every open issue.

This is an editorial file index, not a claim that every field is mandated for every parcel. An actual applicable rule may demand more, while an inapplicable process may not appear in a domestic scenario. The record should explain why a gate was marked not applicable instead of leaving it blank. For example, “no international border in this defined route” is a reason for no outbound customs form review in that scenario; it is not permission to reuse the record for a later export.

Show the primary page and the exact point it supports

A strong source entry includes the URL, access date, page title, the factual point drawn from it, and the item specific applicability decision. USPS's customs page supports the need for detailed international descriptions and tells users that country requirements differ. [1] It does not approve a named item for a named country. The USPS HAZMAT page explains what its search tool returns. [3] It does not supply the result of a search your team has not run. FDA's import pages describe human drug admissibility review and refusal terminology. [4] [5] They do not supply the notice for your actual parcel.

That distinction should appear directly in the evidence column. A useful note might read: “Source establishes the type of check; actual item outcome pending.” When the team later receives a specific response, link it to the question asked and the precise facts supplied. If it cannot be tied to those facts, it remains background guidance. Keeping this distinction is especially important when an operator changes roles and inherits records prepared by someone else.

Work a hypothetical stop from intake to owner

Consider a hypothetical in which you are preparing an unnamed material for a domestic business recipient. The product identifier and physical record match, but the sender's authority under any applicable postal category has not been resolved. The proposed service is listed, yet no item specific carrier result exists. The packer can complete the item row, but must mark legal category and carrier acceptance pending. The final disposition is hold, with a legal reviewer assigned to the classification question and an operations owner assigned to the carrier inquiry. This example establishes no legal status for the material.

Now imagine a hypothetical second order for the same item to another country. The earlier domestic review, even if eventually completed, would not cover the new route. The operations owner opens a new scenario, checks the applicable international service, obtains current destination restrictions, and prepares a truthful customs description from the verified item record. USPS says detailed descriptions are required and country declaration requirements differ. [1] If the destination source cannot be found or interpreted, the file stays on hold for qualified review. A complete domestic folder is background evidence, not an international approval.

Suppose a hypothetical third worker finds a draft customs form whose description does not match the packing record. The worker should not edit the form to a vaguer category and ship. The discrepancy goes to the product record owner, then to the person responsible for the declaration. The final data must describe what is actually enclosed under the applicable instructions. A corrected draft may close the description mismatch, but it does not answer the remaining item, carrier, or destination questions.

Recheck after a meaningful change

An approval belongs to its defined scenario. Recheck when the item or its documented composition changes, a different person or business becomes the sender, the recipient role changes, a new destination is proposed, the parcel contains another component, or a different service is selected. Recheck the source date when the governing page or carrier response changes. The record should show which earlier answer remained applicable and which gate reopened.

To make this sustainable, use a short release note beside the detailed file. Name the approved scenario, its evidence location, its reviewer, and the precise conditions for release. Give the packer a simple comparison task: does today's parcel match every reviewed field? If not, mark hold and identify the changed field. That instruction is more useful than sending a long legal memo into a shipping chat and expecting a worker to interpret it on the fly.

The final record should preserve the actual declaration and any subsequent carrier or agency notice. An adverse event may reveal a missing gate or a mismatch between the reviewed facts and the parcel sent. It does not automatically prove that every prior decision was wrong, and it does not justify a concealed description on the next attempt. Review the documented reason, update the affected scenario, and seek qualified guidance where the meaning is uncertain.

What to do next

1. Identify your exact item and the complete parcel contents with the intake table, and keep the classification question open until a qualified reviewer answers it.

2. Separate the decisions that share a shipping label: whether the transaction is lawful, whether the carrier accepts the material by your chosen service, how the package is prepared, and, if the route crosses a border, customs and destination requirements.

3. Give counsel a transaction rather than a slogan, and ask for a written conclusion with a defined scope.

4. Test the proposed service, and match any USPS HAZMAT result to your actual item and method.

5. For an international route, check the destination country's restrictions and build a truthful customs description from the verified item record.

6. Mark any unresolved field as a hold, with an owner and a condition for renewed review.

7. Name one owner to release a defined scenario, and keep the evidence beside each answer.

8. Recheck whenever the item, sender, recipient, destination, package, or service changes.

When should you book a peptide business fit call?

Book a fit call when you have the item record, proposed route, draft shipment checklist, and unresolved workflow ownership questions. Bring the hold points and any current carrier or agency responses so the conversation can focus on who documents each gate. Get qualified legal and carrier answers for the actual shipment before releasing it.

Frequently Asked Questions

Do carrier rules replace legal review?

No. A carrier response addresses acceptance under that carrier's terms for the facts provided. USPS Publication 52 also makes the mailer responsible for applicable distribution laws. Keep the carrier and legal conclusions as separate entries with separate scopes. [2]

Can a label change shipment rules?

A label alone does not establish the contents, sender authority, or destination permission. Provide reviewers with the actual material and transaction facts, then record the applicable conclusion. Do not use a research label as a substitute for that review.

What changes for international shipping?

The route adds destination requirements and a customs declaration review. USPS says outbound international packages need detailed item descriptions, that countries have different declaration requirements, and that its forms application can show country restrictions. Those statements do not decide whether a particular item may enter the destination. [1]

Who should approve shipping procedures?

Assign an internal owner to release only a defined scenario after the applicable legal, carrier, packaging, and destination questions have answers. Send specialized questions to qualified advisers or the relevant carrier or authority. Preserve who made each determination and when it must be reopened.

Does a USPS search result approve every future order?

No. USPS describes item and method specific HAZMAT results, so a result must be matched to the actual material and proposed service. A later order may have different contents, packaging, parties, or destination, and other legal questions still need answers. [3]

Sources

1. United States Postal Service, "Customs Forms: The Basics,", accessed 2026-09-29. Harvest h_f5957ac5bfcf4e07b48f847465119d4c.

2. United States Postal Service, "Publication 52: 453 Controlled Substances and Drugs,", accessed 2026-09-29. Harvest h_5c5392a85cf74cedba078162557ec920.

3. United States Postal Service, "HAZMAT Search Tool,", accessed 2026-09-29. Harvest h_f478a136d0b34efcb9c9ceef5e31788e.

4. U.S. Food and Drug Administration, "Shipment Admissibility,", accessed 2026-09-29. Harvest h_59b450a4d848464585169c77529ec465.

5. U.S. Food and Drug Administration, "Import Refusals,", accessed 2026-09-29. Harvest h_2553c5dd30d2481f83c7b75d53311e71.

6. U.S. Food and Drug Administration, "Detention & Hearing,", accessed 2026-09-29.

Educational and legal disclaimer

This article is educational information only. It is not legal, regulatory, tax, medical, product, import, platform, or payment advice. It makes no claim about human use or any health outcome. Verify current requirements for the actual item and shipment with the relevant carrier, authorities, and qualified professionals before acting.